1887

Chapter 13 : Decontamination, Disinfection, and Sterilization

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Ebook: Choose a downloadable PDF or ePub file. Chapter is a downloadable PDF file. File must be downloaded within 48 hours of purchase

Buy this Chapter
Digital (?) $30.00

Preview this chapter:
Zoom in
Zoomout

Decontamination, Disinfection, and Sterilization, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555817381/9781555817381.ch13-1.gif /docserver/preview/fulltext/10.1128/9781555817381/9781555817381.ch13-2.gif

Abstract:

Antisepsis of living tissue and decontamination, disinfection, and sterilization of the environment and medical devices are basic components of any infection control program. Patients expect to be treated in a clean environment and that any reusable instrument or device used for diagnosis or treatment has undergone a process to eliminate any risks for cross-infection. Due to the increasing frequency of multiresistant bacterial pathogens at a time when pharmaceutical companies have shifted from developing antimicrobial agents to designing drugs for chronic diseases, reprocessing techniques, disinfectants, and general infection control practice have garnered more attention recently than in the past.This chapter describes substances and procedures used for antisepsis, decontamination, disinfection, and sterilization and highlights some special issues like decolonization of colonized patients, reprocessing of endoscopes or dental equipment, and reprocessing of medical devices contaminated with prions.

Citation: Wendt C, Frei R, Widmer A. 2015. Decontamination, Disinfection, and Sterilization, p 183-216. In Jorgensen J, Pfaller M, Carroll K, Funke G, Landry M, Richter S, Warnock D (ed), Manual of Clinical Microbiology, Eleventh Edition. ASM Press, Washington, DC. doi: 10.1128/9781555817381.ch13
Highlighted Text: Show | Hide
Loading full text...

Full text loading...

Figures

Image of FIGURE 1
FIGURE 1

Microorganisms’ resistance to disinfectants. HSV, herpes simplex virus; CMV, cytomegalovirus; RSV, respiratory syncytial virus. doi:10.1128/9781555817381.ch13.f1

Citation: Wendt C, Frei R, Widmer A. 2015. Decontamination, Disinfection, and Sterilization, p 183-216. In Jorgensen J, Pfaller M, Carroll K, Funke G, Landry M, Richter S, Warnock D (ed), Manual of Clinical Microbiology, Eleventh Edition. ASM Press, Washington, DC. doi: 10.1128/9781555817381.ch13
Permissions and Reprints Request Permissions
Download as Powerpoint

References

/content/book/10.1128/9781555817381.mcm11.ch13
1. Biron F,, Verrier B,, Peyramond D. 1997. Transmission of the human immunodeficiency virus and the hepatitis C virus. N Engl J Med 337:348349.
2. Gillespie TG,, Hogg L,, Budge E,, Duncan A,, Coia JE. 2000. Mycobacterium chelonae isolated from rinse water within an endoscope washer-disinfector. J Hosp Infect 45:332334.
3. Schelenz S,, French G. 2000. An outbreak of multidrug-resistant Pseudomonas aeruginosa infection associated with contamination of bronchoscopes and an endoscope washer-disinfector. J Hosp Infect 46:2330.
4. Spach DH,, Silverstein FE,, Stamm WE. 1993. Transmission of infection by gastrointestinal endoscopy and bronchoscopy. Ann Intern Med 118:117128.
5. Srinivasan A,, Wolfenden LL,, Song X,, Mackie K,, Hartsell TL,, Jones HD,, Diette GB,, Orens JB,, Yung RC,, Ross TL,, Merz W,, Scheel PJ,, Haponik EF,, Perl TM. 2003. An outbreak of Pseudomonas aeruginosa infections associated with flexible bronchoscopes. N Engl J Med 348:221227.
6. Block SS. 2001. Disinfection, Sterilization, and Preservation. Lippincott Williams & Wilkins, Philadelphia, PA.
7. McDonnell G,, Russell AD. 1999. Antiseptics and disinfectants: activity, action, and resistance. Clin Microbiol Rev 12:147179.
8. Russell AD,, Hugo WB,, Ayliffe GAJ. 1992. Principles and Practice of Disinfection, Preservation and Sterilization. Blackwell Scientific Publications, London, United Kingdom.
9. Wenzel RP. 2004. The antibiotic pipeline—challenges, costs, and values. N Engl J Med 351:523526.
10. Holmes KV. 2003. SARS-associated coronavirus. N Engl J Med 348:19481951.
11. Neumann G,, Noda T,, Kawaoka Y. 2009. Emergence and pandemic potential of swine-origin H1N1 influenza virus. Nature 459:931939.
12. Rutala WA,, Weber DJ. 2010. Guideline for disinfection and sterilization of prion-contaminated medical instruments. Infect Control Hosp Epidemiol 31:107117.
13. Evans RJ. 1992. Acute anaphylaxis due to topical chlorhexidine acetate. BMJ 304:686.
14. Parker F,, Foran S. 1995. Chlorhexidine catheter lubricant anaphylaxis. Anaesth Intensive Care 23:126.
15. Kramer A,, Below H,, Bieber N,, Kampf G,, Toma CD,, Huebner NO,, Assadian O. 2007. Quantity of ethanol absorption after excessive hand disinfection using three commercially available hand rubs is minimal and below toxic levels for humans. BMC Infect Dis 11:117.
16. Turner P,, Saeed B,, Kelsey MC. 2004. Dermal absorption of isopropyl alcohol from a commercial hand rub: implications for its use in hand decontamination. J Hosp Infect 56:287290.
17. Rotter MA,. 1996. Alcohols for antisepsis of hands and skin, p 177234. In Ascenzi JP (ed), Handbook of Disinfectants and Antiseptics. Marcel Dekker, Inc, New York, NY.
18. Larson EL,. 1991. Alcohols, p 191203. In Block SS (ed), Disinfection, Sterilization and Preservation. Lea & Febiger, Philadelphia, PA.
19. Saurina G,, Landman D,, Quale JM. 1997. Activity of disinfectants against vancomycin-resistant Enterococcus faecium. Infect Control Hosp Epidemiol 18:345347.
20. Rutala WA, , et al. 1996. APIC guideline for selection and use of disinfectants. Am J Infect Control 24:313342.
21. Klein M,, DeForest A. 1963. The inactivation of viruses by germicides. Chem Specialists Manuf Assoc Proc 49:116118.
22. Mbithi JN,, Springthorpe VS,, Sattar SA. 1990. Chemical disinfection of hepatitis A virus on environmental surfaces. Appl Environ Microbiol 56:36013604.
23. Bond WW,, Favero MS,, Petersen NJ,, Ebert JW. 1983. Inactivation of hepatitis B virus by intermediate-to-high-level disinfectant chemicals. J Clin Microbiol 18:535538.
24. Kobayashi H,, Tsuzuki M,, Koshimizu K,, Toyama H,, Yoshihara N,, Shikata T,, Abe K,, Mizuno K,, Otomo N,, Oda T. 1984. Susceptibility of hepatitis B virus to disinfectants or heat. J Clin Microbiol 20:214216.
25. Martin LS,, McDougal JS,, Loskoski SL. 1985. Disinfection and inactivation of the human T lymphotropic virus type III/lymphadenopathy-associated virus. J Infect Dis 152:400403.
26. van Bueren J,, Larkin DP,, Simpson RA. 1994. Inactivation of human immunodeficiency virus type 1 by alcohols. J Hosp Infect 28:137148.
27. Kurtz JB,, Lee TW,, Parsons AJ. 1980. The action of alcohols on rotavirus, astrovirus and enterovirus. J Hosp Infect 1:321325.
28. Ansari SA,, Sattar SA,, Springthorpe VS,, Wells GA,, Tostowaryk W. 1989. In vivo protocol for testing efficacy of hand-washing agents against viruses and bacteria: experiments with rotavirus and Escherichia coli. Appl Environ Microbiol 55:31133118.
29. Denton GE,. 1991. Chlorhexidine, p 274289. In os [cvNormal]?>Block SS (ed), Disinfection, Sterilization and Preservation. Lea & Febiger, Philadelphia, PA.
30. Ranganathan NS,. 1996. Chlorhexidine, p 235264. In os [cvNormal]?>Ascenzi JP (ed), Handbook of Disinfectants and Antiseptics. Marcel Dekker, Inc, New York, NY.
31. Maki DG,, Stolz SM,, Wheeler S,, Mermel LA. 1997. Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter. A randomized, controlled trial. Ann Intern Med 127:257266.
32. Pronovost P,, Needham D,, Berenholtz S,, Sinopoli D,, Chu H,, Cosgrove S,, Sexton B,, Hyzy R,, Welsh R,, Roth G,, Bander J,, Kepros J,, Goeschel C. 2006. An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med 355:27252732.
33. Milstone AM,, Passaretti CL,, Perl TM. 2008. Chlorhexidine: expanding the armamentarium for infection control and prevention. Clin Infect Dis 46:274281.
34. Larson EL,, Butz AM,, Gullette DL,, Laughon BA. 1990. Alcohol for surgical scrubbing? Infect Control Hosp Epidemiol 11:139143.
35. Dennis DT,, Inglesby TV,, Henderson DA,, Bartlett JG,, Ascher MS,, Eitzen E,, Fine AD,, Friedlander AM,, Hauer J,, Layton M,, Lillibridge SR,, McDade JE,, Osterholm MT,, O’Toole T,, Parker G,, Perl TM,, Russell PK,, Tonat K. 2001. Tularemia as a biological weapon: medical and public health management. JAMA 285:27632773.
36. Lowbury EJ,, Lilly HA. 1974. The effect of blood on disinfection of surgeons’ hands. Br J Surg 61:1921.
37. Oie S,, Kamiya A. 1996. Microbial contamination of antiseptics and disinfectants. Am J Infect Control 24:389395.
38. Stickler DJ. 1974. Chlorhexidine resistance in Proteus mirabilis. J Clin Pathol 27:284287.
39. Stickler DJ,, Thomas B. 1980. Antiseptic and antibiotic resistance in Gram-negative bacteria causing urinary tract infection. J Clin Pathol 33:288296.
40. Mayer S,, Boos M,, Beyer A,, Fluit AC,, Schmitz FJ. 2001. Distribution of the antiseptic resistance genes qacA, qacB and qacC in 497 methicillin-resistant and -susceptible European isolates of Staphylococcus aureus. J Antimicrob Chemother 47:896897.
41. Mitchell BA,, Brown MH,, Skurray RA. 1998. QacA multidrug efflux pump from Staphylococcus aureus: comparative analysis of resistance to diamidines, biguanidines, and guanylhydrazones. Antimicrob Agents Chemother 42:475477.
42. Yong D,, Parker FC,, Foran SM. 1995. Severe allergic reactions and intra-urethral chlorhexidine gluconate. Med J Aust 162:257258.
43. Tabor E,, Bostwick DC,, Evans CC. 1989. Corneal damage due to eye contact with chlorhexidine gluconate. JAMA 261:557558.
44. Marschall J,, Mermel LA, , et al. 2008. Strategies to prevent central line-associated bloodstream infections in acute care hospitals. Infect Control Hosp Epidemiol 29(Suppl 1):S22S30.
45. Tamma PD,, Aucott SW,, Milstone AM. 2010. Chlorhexidine use in the neonatal intensive care unit: results from a national survey. Infect Control Hosp Epidemiol 31:846849.
46. Gottardi W,. 1991. Iodine and iodine compounds, p 152166. In Block SS (ed), Disinfection, Sterilization and Preservation. Lea & Febiger, Philadelphia, PA.
47. Berkelman RL,, Holland BW,, Anderson RL. 1982. Increased bactericidal activity of dilute preparations of povidone-iodine solutions. J Clin Microbiol 15:635639.
48. Berkelman RL,, Lewin S,, Allen JR,, Anderson RL,, Budnick LD,, Shapiro S,, Friedman SM,, Nicholas P,, Holzman RS,, Haley RW. 1981. Pseudobacteremia attributed to contamination of povidone-iodine with Pseudomonas cepacia. Ann Intern Med 95:3236.
49. Craven DE,, Moody B,, Connolly MG,, Kollisch NR,, Stottmeier KD,, McCabe WR. 1981. Pseudobacteremia caused by povidone-iodine solution contaminated with Pseudomonas cepacia. N Engl J Med 305:621623.
50. Anderson RL,, Vess RW,, Panlilio AL,, Favero MS. 1990. Prolonged survival of Pseudomonas cepacia in commercially manufactured povidone-iodine. Appl Environ Microbiol 56:35983600.
51. Isenberg SJ,, Apt L,, Wood M. 1995. A controlled trial of povidone-iodine as prophylaxis against ophthalmia neonatorum. N Engl J Med 332:562566.
52. Arata T,, Murakami T,, Hirai Y. 1993. Evaluation of povidone-iodine alcoholic solution for operative site disinfection. Postgrad Med J 69(Suppl 3):S93S96.
53. Bryant WP,, Zimmerman D. 1995. Iodine-induced hyperthyroidism in a newborn. Pediatrics 95:434436.
54. Waran KD,, Munsick RA. 1995. Anaphylaxis from povidone-iodine. Lancet 345:1506.
55. Jones RD,, Jampani HB,, Newman JL,, Lee AS. 2000. Triclosan: a review of effectiveness and safety in health care settings. Am J Infect Control 28:184196.
56. Suller MT,, Russell AD. 2000. Triclosan and antibiotic resistance in Staphylococcus aureus. J Antimicrob Chemother 46:1118.
57. Aiello AE,, Larson E. 2003. Antibacterial cleaning and hygiene products as an emerging risk factor for antibiotic resistance in the community. Lancet Infect Dis 3:501506.
58. Chuanchuen R,, Beinlich K,, Hoang TT,, Becher A,, Karkhoff-Schweizer RR,, Schweizer HP. 2001. Cross-resistance between triclosan and antibiotics in Pseudomonas aeruginosa is mediated by multidrug efflux pumps: exposure of a susceptible mutant strain to triclosan selects nfxB mutants overexpressing MexCD-OprJ. Antimicrob Agents Chemother 45:428432.
59. Russell AD. 2004. Whither triclosan? J Antimicrob Chemother 53:693695.
60. Ghannoum MA,, Elteen KA,, Ellabib M,, Whittaker PA. 1990. Antimycotic effects of octenidine and pirtenidine. J Antimicrob Chemother 25:237245.
61. Sedlock DM,, Bailey DM. 1985. Microbicidal activity of octenidine hydrochloride, a new alkanediylbis[pyridine] germicidal agent. Antimicrob Agents Chemother 28:786790.
62. Beiswanger BB,, Mallatt ME,, Mau MS,, Jackson RD,, Hennon DK. 1990. The clinical effects of a mouthrinse containing 0.1% octenidine. J Dent Res 69:454457.
63. Tietz A,, Frei R,, Dangel M,, Bolliger D,, Passweg JR,, Gratwohl A,, Widmer AE. 2005. Octenidine hydrochloride for the care of central venous catheter insertion sites in severely immunocompromised patients. Infect Control Hosp Epidemiol 26:703707.
64. Dettenkofer M,, Wilson C,, Gratwohl A,, Schmoor C,, Bertz H,, Frei R,, Heim D,, Luft D,, Schulz S,, Widmer AF. 2010. Skin disinfection with octenidine dihydrochloride for central venous catheter site care: a double-blind, randomized, controlled trial. Clin Microbiol Infect 16:600606.
65. Boyce JM,, Pittet D. 2002. Guideline for hand hygiene in health-care settings: recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. Infect Control Hosp Epidemiol 23:S3S40.
66. Doebbeling BN,, Stanley GL,, Sheetz CT,, Pfaller MA,, Houston AK,, Annis L,, Li N,, Wenzel RP. 1992. Comparative efficacy of alternative hand-washing agents in reducing nosocomial infections in intensive care units. N Engl J Med 327:8893.
67. Kampf G,, Kramer A. 2004. Epidemiologic background of hand hygiene and evaluation of the most important agents for scrubs and rubs. Clin Microbiol Rev 17:863893.
68. Trampuz A,, Widmer AF. 2004. Hand hygiene: a frequently missed lifesaving opportunity during patient care. Mayo Clin Proc 79:109116.
69. Widmer AF. 2000. Replace hand washing with use of a waterless alcohol hand rub? Clin Infect Dis 31:136143.
70. Price PB. 1938. The bacteriology of normal skin; a new quantitative test applied to a study of the bacterial biota and the disinfectant action of mechanical cleansing. J Infect Dis 63:301318.
71. Im SW,, Fung JP,, So SY,, Yu DY. 1982. Unusual dissemination of pseudomonads by ventilators. Anaesthesia 37:10741077.
72. Adams BG,, Marrie TJ. 1982. Hand carriage of aerobic Gram-negative rods may not be transient. J Hyg (London) 89:3346.
73. Boyce JM,, Potter-Bynoe G,, Opal SM,, Dziobek L,, Medeiros AA. 1990. A common-source outbreak of Staphylococcus epidermidis infections among patients undergoing cardiac surgery. J Infect Dis 161:493499.
74. Rutala WA,, Weber DJ,, Thomann CA,, John JF,, Saviteer SM,, Sarubbi FA. 1988. An outbreak of Pseudomonas cepacia bacteremia associated with a contaminated intra-aortic balloon pump. J Thorac Cardiovasc Surg 96:157161.
75. Samore MH,, Venkataraman L,, DeGirolami PC,, Arbeit RD,, Karchmer AW. 1996. Clinical and molecular epidemiology of sporadic and clustered cases of nosocomial Clostridium difficile diarrhea. Am J Med 100:3240.
76. Widmer AF,, Wenzel RP,, Trilla A,, Bale MJ,, Jones RN,, Doebbeling BN. 1993. Outbreak of Pseudomonas aeruginosa infections in a surgical intensive care unit: probable transmission via hands of a health care worker. Clin Infect Dis 16:372376.
77. Zaidi M,, Sifuentes J,, Bobadilla M,, Moncada D,, Ponce de León S. 1989. Epidemic of Serratia marcescens bacteremia and meningitis in a neonatal unit in Mexico City. Infect Control Hosp Epidemiol 10:1420.
78. Rotter ML,, Simpson RA,, Koller W. 1998. Surgical hand disinfection with alcohols at various concentrations: parallel experiments using the new proposed European standards method. Infect Control Hosp Epidemiol 19:778781.
79. Pittet D,, Hugonnet S,, Harbarth S,, Mourouga P,, Sauvan V,, Touveneau S,, Perneger TV. 2000. Effectiveness of a hospital-wide programme to improve compliance with hand hygiene. Lancet 356:13071312.
80. Bellamy K,, Alcock R,, Babb JR,, Davies JG,, Ayliffe GA. 1993. A test for the assessment of ‘hygienic’ hand disinfection using rotavirus. J Hosp Infect 24:201210.
81. Rotter ML,, Koller W,, Wewalka G,, Werner HP,, Ayliffe GA,, Babb JR. 1986. Evaluation of procedures for hygienic hand-disinfection: controlled parallel experiments on the Vienna test model. J Hyg (London) 96:2737.
82. Mermel LA,, Josephson SL,, Dempsey J,, Parenteau S,, Perry C,, Magill N. 1997. Outbreak of Shigella sonnei in a clinical microbiology laboratory. J Clin Microbiol 35:31633165.
83. Katz KC,, McGeer A,, Low DE,, Willey BM. 2002. Laboratory contamination of specimens with quality control strains of vancomycin-resistant enterococci in Ontario. J Clin Microbiol 40:26862688.
84. Boyce JM,, Pearson ML. 2003. Low frequency of fires from alcohol-based hand rub dispensers in healthcare facilities. Infect Control Hosp Epidemiol 24:618619.
85. Kramer A,, Kampf G. 2007. Hand rub-associated fire incidents during 25,038 hospital-years in Germany. Infect Control Hosp Epidemiol 28:745746.
86. Cruse PJ,, Foord R. 1973. A five-year prospective study of 23,649 surgical wounds. Arch Surg 107:206210.
87. Furuhashi M,, Miyamae T. 1979. Effect of pre-operative hand scrubbing and influence of pinholes appearing in surgical rubber gloves during operation. Bull Tokyo Med Dent Univ 26:7380.
88. Misteli H,, Weber WP,, Reck S,, Rosenthal R,, Zwahlen M,, Fueglistaler P,, Bolli MK,, Oertli D,, Widmer AF,, Marti WR. 2009. Surgical glove perforation and the risk of surgical site infection. Arch Surg 144:553558.
89. Fuursted K,, Hjort A,, Knudsen L. 1997. Evaluation of bactericidal activity and lag of regrowth (postantibiotic effect) of five antiseptics on nine bacterial pathogens. J Antimicrob Chemother 40:221226.
90. Widmer AF. 2009. Surgical hand antisepsis, p 5460. In World Health Organization (ed), WHO Guidelines on Hand Hygiene in Health Care. World Health Organization, Geneva, Switzerland.
91. Widmer AF,, Rotter M,, Voss A,, Nthumba P,, Allegranzi B,, Boyce J,, Pittet D. 2009. Surgical hand preparation: state-of-the-art. J Hosp Infect 74:112122.
92. Blanc DS,, Nahimana I,, Petignat C,, Wenger A,, Bille J,, Francioli P. 2004. Faucets as a reservoir of endemic Pseudomonas aeruginosa colonization/infections in intensive care units. Intensive Care Med 30:19641968.
93. Kramer A,, Rudolph P,, Kampf G,, Pittet D. 2002. Limited efficacy of alcohol-based hand gels. Lancet 359:14891490.
94. Kampf G,, Ostermeyer C,, Heeg P. 2005. Surgical hand disinfection with a propanol-based hand rub: equivalence of shorter application times. J Hosp Infect 59:304310.
95. Weber WP,, Reck S,, Neff U,, Saccilotto R,, Dangel M,, Rotter ML,, Frei R,, Oertli D,, Marti WR,, Widmer AF. 2009. Surgical hand antisepsis with alcohol-based hand rub: comparison of effectiveness after 1.5 and 3 minutes of application. Infect Control Hosp Epidemiol 30:420426.
96. Garibaldi RA,, Skolnick D,, Lerer T,, Poirot A,, Graham J,, Krisuinas E,, Lyons R. 1988. The impact of preoperative skin disinfection on preventing intraoperative wound contamination. Infect Control Hosp Epidemiol 9:109113.
97. Federal Register. 1994. Tentative final monograph for health-care antiseptic drug products. Fed Regist 59:3140131452.
98. Georgiade G,, Riefkohl R,, Georgiade N,, Georgiade R,, Wildman MF. 1985. Efficacy of povidone-iodine in pre-operative skin preparation. J Hosp Infect 6(Suppl A):6771.
99. Swenson BR,, Hedrick TL,, Metzger R,, Bonatti H,, Pruett TL,, Sawyer RG. 2009. Effects of preoperative skin preparation on postoperative wound infection rates: a prospective study of 3 skin preparation protocols. Infect Control Hosp Epidemiol 30:964971.
100. Darouiche RO,, Wall MJJr,, Itani KM,, Otterson MF,, Webb AL,, Carrick MM,, Miller HJ,, Awad SS,, Crosby CT,, Mosier MC,, Alsharif A,, Berger DH. 2010. Chlorhexidine-alcohol versus povidone-iodine for surgical-site antisepsis. N Engl J Med 362:1826.
101. Tschudin-Sutter S,, Frei R,, Egli-Gany D,, Eckstein F,, Valderrabano V,, Dangel M,, Battegay M,, Widmer AF. 2012. No risk of surgical site infections from residual bacteria after disinfection with povidone-iodine-alcohol in 1,014 cases: a prospective observational study. Ann Surg 255:565569.
102. Dumville JC,, McFarlane E,, Edwards P,, Lipp A,, Holmes A. 2013. Preoperative skin antiseptics for preventing surgical wound infections after clean surgery. Cochrane Database Syst Rev 28:CD003949.
103. Mangram AJ,, Horan TC,, Pearson ML,, Silver LC,, Jarvis WR, , et al. 1999. Guideline for prevention of surgical site infection, 1999. Infect Control Hosp Epidemiol 20:250278.
104. Webster J,, Osborne S. 2012. Preoperative bathing or showering with skin antiseptics to prevent surgical site infection. Cochrane Database Syst Rev 12:CD004985.
105. Rotter ML,, Larsen SO,, Cooke EM,, Dankert J,, Daschner F,, Greco D,, Gronross P,, Jepsen OB,, Lystad A,, Nystrom B, , et al. 1988. A comparison of the effects of preoperative whole-body bathing with detergent alone and with detergent containing chlorhexidine gluconate on the frequency of wound infections after clean surgery. J Hosp Infect 11:310320.
106. Lowbury EJ,, Lilly HA,, Bull JP. 1964. Methods for disinfection of operation sites. Br Med J 2:531533.
107. Hill RL,, Casewell MW. 2000. The in-vitro activity of povidone-iodine cream against Staphylococcus aureus and its bioavailability in nasal secretions. J Hosp Infect 45:198205.
108. Kramer A,, Roth B,, Müller G,, Rudolph P,, Klöcker N. 2004. Influence of the antiseptic agents polyhexanide and octenidine on FL cells and on healing of experimental superficial aseptic wounds in piglets. A double-blind, randomised, stratified, controlled, parallel-group study. Skin Pharmacol Physiol 17:141146.
109. Block C,, Robenshtok E,, Simhon A,, Shapiro M. 2000. Evaluation of chlorhexidine and povidone iodine activity against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecalis using a surface test. J Hosp Infect 46:147152.
110. Davies J,, Babb JR,, Ayliffe GA. 1977. The effect on the skin flora of bathing with antiseptic solutions. J Antimicrob Chemother 3:473481.
111. Ayliffe GA,, Noy MF,, Babb JR,, Davies JG,, Jackson J. 1983. A comparison of pre-operative bathing with chlorhexidine-detergent and non-medicated soap in the prevention of wound infection. J Hosp Infect 4:237244.
112. Wendt C,, Schinke S,, Württemberger M,, Oberdorfer K,, Bock-Hensley O,, von Baum H. 2007. Value of whole-body washing with chlorhexidine for the eradication of methicillin-resistant Staphylococcus aureus: a randomized, placebo-controlled, double-blind clinical trial. Infect Control Hosp Epidemiol 28:10361043.
113. Leigh DA,, Stronge JL,, Marriner J,, Sedgwick J. 1983. Total body bathing with ‘Hibiscrub’ (chlorhexidine) in surgical patients: a controlled trial. J Hosp Infect 4:229235.
114. Ridenour G,, Lampen R,, Federspiel J,, Kritchevsky S,, Wong E,, Climo M. 2007. Selective use of intranasal mupirocin and chlorhexidine bathing and the incidence of methicillin-resistant Staphylococcus aureus colonization and infection among intensive care unit patients. Infect Control Hosp Epidemiol 28:11551161.
115. Hayek LJ,, Emerson JM,, Gardner AM. 1987. A placebo-controlled trial of the effect of two preoperative baths or showers with chlorhexidine detergent on postoperative wound infection rates. J Hosp Infect 10:165172.
116. Cox RA,, Conquest C. 1997. Strategies for the management of healthcare staff colonized with epidemic methicillin-resistant Staphylococcus aureus. J Hosp Infect 35:117127.
117. Valls V,, Gómez-Herruz P,, González-Palacios R,, Cuadros JA,, Romanyk JP,, Ena J. 1994. Long-term efficacy of a program to control methicillin-resistant Staphylococcus aureus. Eur J Clin Microbiol Infect Dis 13:9095.
118. Kotilainen P,, Routamaa M,, Peltonen R,, Evesti P,, Eerola E,, Salmenlinna S,, Vuopio-Varkila J,, Rossi T. 2001. Eradication of methicillin-resistant Staphylococcus aureus from a health center ward and associated nursing home. Arch Intern Med 161:859863.
119. Watanakunakorn C,, Axelson C,, Bota B,, Stahl C. 1995. Mupirocin ointment with and without chlorhexidine baths in the eradication of Staphylococcus aureus nasal carriage in nursing home residents. Am J Infect Control 23:306309.
120. Sandri AM,, Dalarosa MG,, Ruschel de Alcantara L,, da Silva Elias L,, Zavascki AP. 2006. Reduction in incidence of nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection in an intensive care unit: role of treatment with mupirocin ointment and chlorhexidine baths for nasal carriers of MRSA. Infect Control Hosp Epidemiol 27:185187.
121. Huang SS,, Septimus E,, Kleinman K,, Moody J,, Hickok J,, Avery TR,, Lankiewicz J,, Gombosev A,, Terpstra L,, Hartford F,, Hayden MK,, Jernigan JA,, Weinstein RA,, Fraser VJ,, Haffenreffer K,, Cui E,, Kaganov RE,, Lolans K,, Perlin JB,, Platt R,, CDC Prevention Epicenters Program,, AHRQ DECIDE Network and Healthcare-Associated Infections Program. 2013. Targeted versus universal decolonization to prevent ICU infection. N Engl J Med 368:22552265.
122. Rohr U,, Mueller C,, Wilhelm M,, Muhr G,, Gatermann S. 2003. Methicillin-resistant Staphylococcus aureus whole-body decolonization among hospitalized patients with variable site colonization by using mupirocin in combination with octenidine dihydrochloride. J Hosp Infect 54:305309.
123. Sloot N,, Siebert J,, Hoffler U. 1999. Eradication of MRSA from carriers by means of whole-body washing with an antiseptic in combination with mupirocin nasal ointment. Zentralbl Hyg Umweltmed 202:513523.
124. Cohen SH,, Morita MM,, Bradford M. 1991. A seven-year experience with methicillin-resistant Staphylococcus aureus. Am J Med 91:233S237S.
125. Zafar AB,, Butler RC,, Reese DJ,, Gaydos LA,, Mennonna PA. 1995. Use of 0.3% triclosan (Bacti-Stat) to eradicate an outbreak of methicillin-resistant Staphylococcus aureus in a neonatal nursery. Am J Infect Control 23:200208.
126. Nguyen DM,, Mascola L,, Brancoft E. 2005. Recurring methicillin-resistant Staphylococcus aureus infections in a football team. Emerg Infect Dis 11:526532.
127. Wilcox MH,, Hall J,, Gill AB,, Fawley WN,, Parnell P,, Verity P. 2004. Effectiveness of topical chlorhexidine powder as an alternative to hexachlorophane for the control of Staphylococcus aureus in neonates. J Hosp Infect 56:156159.
128. Kampf G,, Kramer A. 2004. Eradication of methicillin-resistant Staphylococcus aureus with an antiseptic soap and nasal mupirocin among colonized patients—an open uncontrolled clinical trial. Ann Clin Microbiol Antimicrob 3:9.
129. Fukunaga A,, Naritaka H,, Fukaya R,, Tabuse M,, Nakamura T. 2004. Povidone-iodine ointment and gauze dressings associated with reduced catheter-related infection in seriously ill neurosurgical patients. Infect Control Hosp Epidemiol 25:696698.
130. Reimer K,, Wichelhaus TA,, Schäfer V,, Rudolph P,, Kramer A,, Wutzler P,, Ganzer D,, Fleischer W. 2002. Antimicrobial effectiveness of povidone-iodine and consequences for new application areas. Dermatology 204(Suppl 1):114120.
131. Seaman PF,, Ochs D,, Day MJ. 2007. Small-colony variants: a novel mechanism for triclosan resistance in methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother 59:4350.
132. Bayston R,, Ashraf W,, Smith T. 2007. Triclosan resistance in methicillin-resistant Staphylococcus aureus expressed as small colony variants: a novel mode of evasion of susceptibility to antiseptics—authors’ response. J Antimicrob Chemother 60:176177.
133. Brenwald NP,, Fraise AP. 2003. Triclosan resistance in methicillin-resistant Staphylococcus aureus (MRSA). J Hosp Infect 55:141144
134. Ringberg H,, Petersson AC,, Walder M,, Johansson PJH. 2006. The throat: an important site for MRSA colonization. Scand J Infect Dis 38:888893.
135. Brook I,, Foote PA. 2006. Isolation of methicillin resistant Staphylococcus aureus from the surface and core of tonsils in children. Int J Pediatr Otorhinolaryngol 70:20992102.
136. Pitten FA,, Werner HP,, Kramer A. 2003. A standardized test to assess the impact of different organic challenges on the antimicrobial activity of antiseptics. J Hosp Infect 55:108115.
137. Tomás I,, Alvarez M,, Limeres J,, Tomás M,, Medina J,, Otero JL,, Diz P. 2007. Effect of a chlorhexidine mouthwash on the risk of postextraction bacteremia. Infect Control Hosp Epidemiol 28:577582.
138. Pitten FA,, Kiefer T,, Buth C,, Doelken G,, Kramer A. 2003. Do cancer patients with chemotherapy-induced leukopenia benefit from an antiseptic chlorhexidine-based oral rinse? A double-blind, block-randomized, controlled study. J Hosp Infect 53:283291.
139. van Steenberghe D. 1997. Breath malodor. Curr Opin Periodontol 4:137143.
140. Clavero J,, Baca P,, Junco P,, González MP. 2003. Effects of 0.2% chlorhexidine spray applied once or twice daily on plaque accumulation and gingival inflammation in a geriatric population. J Clin Periodontol 30:773777.
141. Leenders AC,, Renders NR,, Pelk M,, Janssen M. 2005. Tonsillectomy for treatment of persistent methicillin-resistant Staphylococcus aureus throat carriage. J Hosp Infect 59:266267.
142. Patterson P. 2009. CDC sterilization, disinfection guideline. OR Manager 25:1416.
143. Fichet G,, Comoy E,, Duval C,, Antloga K,, Dehen C,, Charbonnier A,, McDonnell G,, Brown P,, Lasmezas CI,, Deslys JP. 2004. Novel methods for disinfection of prion-contaminated medical devices. Lancet 364:521526.
144. Hanson PJ,, Jeffries DJ,, Collins JV. 1991. Viral transmission and fibreoptic endoscopy. J Hosp Infect 18(Suppl A):136140.
145. Nelson DB,, Jarvis WR,, Rutala WA,, Foxx-Orenstein AE,, Isenberg G,, Dash GR,, Alvarado CJ,, Ball M,, Griffin-Sobel J,, Petersen C,, Ball KA,, Henderson J,, Stricof RL, , et al. 2003. Multi-society guideline for reprocessing flexible gastrointestinal endoscopes. Infect Control Hosp Epidemiol 24:532537.
146. Alfa MJ,, DeGagne P,, Olson N. 1997. Bacterial killing ability of 10% ethylene oxide plus 90% hydrochlorofluorocarbon sterilizing gas. Infect Control Hosp Epidemiol 18:641645.
147. Dharan S,, Mourouga P,, Copin P,, Bessmer G,, Tschanz B,, Pittet D. 1999. Routine disinfection of patients’ environmental surfaces. Myth or reality? J Hosp Infect 42:113117.
148. Sehulster L,, Chinn RY. 2003. Guidelines for environmental infection control in health-care facilities. Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee (HICPAC). MMWR Recommend. Rep. 52:142.
149. Weber DJ,, Rutala WA,, Sickbert-Bennett EE. 2007. Outbreaks associated with contaminated antiseptics and disinfectants. Antimicrob Agents Chemother 51:42174224.
150. Reiss I,, Borkhardt A,, Fussle R,, Sziegoleit A,, Gortner L. 2000. Disinfectant contaminated with Klebsiella oxytoca as a source of sepsis in babies. Lancet 356:310.
151. Astagneau P,, Desplaces N,, Vincent V,, Chicheportiche V,, Botherel A,, Maugat S,, Lebascle K,, Leonard P,, Desenclos J,, Grosset J,, Ziza J,, Brucker G. 2001. Mycobacterium xenopi spinal infections after discovertebral surgery: investigation and screening of a large outbreak. Lancet 358:747751.
152. Tyler R,, Ayliffe GA,, Bradley C. 1990. Virucidal activity of disinfectants: studies with the poliovirus. J Hosp Infect 15:339345.
153. Rutala WA,, Weber DJ. 1995. FDA labeling requirements for disinfection of endoscopes: a counterpoint. Infect Control Hosp Epidemiol 16:231235.
154. Hanson PJ,, Gor D,, Clarke JR,, Chadwick MV,, Gazzard B,, Jeffries DJ,, Gaya H,, Collins JV. 1991. Recovery of the human immunodeficiency virus from fibreoptic bronchoscopes. Thorax 46:410412.
155. Ascenzi JM,. 1996. Glutaraldehyde-based disinfectants, p 111132. In Ascenzi JP (ed), Handbook of Disinfectants and Antiseptics. Marcel Dekker, Inc, New York, NY.
156. Russell AD. 1994. Glutaraldehyde: current status and uses. Infect Control Hosp Epidemiol 15:724733.
157. Gelinas P,, Goulet J,, Tastayre GM,, Picard GA. 1991. Effect of temperature and contact time on the activity of eight disinfectants—a classification. J Food Prot 47:841847.
158. Rutala WA,, Gergen MF,, Weber DJ. 1993. Inactivation of Clostridium difficile spores by disinfectants. Infect Control Hosp Epidemiol 14:3639.
159. Wilson JA,, Margolin AB. 1999. The efficacy of three common hospital liquid germicides to inactivate Cryptosporidium parvum oocysts. J Hosp Infect 42:231237.
160. Rubbo SD,, Gardner JF,, Webb RL. 1967. Biocidal activities of glutaraldehyde and related compounds. J Appl Bacteriol 30:7887.
161. Collins FM. 1986. Kinetics of the tuberculocidal response by alkaline glutaraldehyde in solution and on an inert surface. J Appl Bacteriol 61:8793.
162. Collins FM. 1986. Bactericidal activity of alkaline glutaraldehyde solution against a number of atypical mycobacterial species. J Appl Bacteriol 61:247251.
163. Jackson J,, Leggett JE,, Wilson DA,, Gilbert DN. 1996. Mycobacterium gordonae in fiberoptic bronchoscopes. Am J Infect Control 24:1923.
164. Griffiths PA,, Babb JR,, Bradley CR,, Fraise AP. 1997. Glutaraldehyde-resistant Mycobacterium chelonae from endoscope washer disinfectors. J Appl Microbiol 82:519526.
165. Van Klingeren B,, Pullen W. 1993. Glutaraldehyde resistant mycobacteria from endoscope washers. J Hosp Infect 25:147149.
166. Mbithi JN,, Springthorpe VS,, Sattar SA,, Pacquette M. 1993. Bactericidal, virucidal, and mycobactericidal activities of reused alkaline glutaraldehyde in an endoscopy unit. J Clin Microbiol 31:29882995.
167. Alvarado CJ,, Reichelderfer M, , et al. 2000. APIC guideline for infection prevention and control in flexible endoscopy. Am J Infect Control 28:138155.
168. Dolce P,, Gourdeau M,, April N,, Bernard PM. 1995. Outbreak of glutaraldehyde-induced proctocolitis. Am J Infect Control 23:3439.
169. West AB,, Kuan SF,, Bennick M,, Lagarde S. 1995. Glutaraldehyde colitis following endoscopy: clinical and pathological features and investigation of an outbreak. Gastroenterology 108:12501255.
170. Brown P,, Liberski PP,, Wolff A,, Gajdusek DC. 1990. Resistance of scrapie infectivity to steam autoclaving after formaldehyde fixation and limited survival after ashing at 360 degrees C: practical and theoretical implications. J Infect Dis 161:467472.
171. Fraud S,, Maillard JY,, Russell AD. 2001. Comparison of the mycobactericidal activity of ortho-phthalaldehyde, glutaraldehyde and other dialdehydes by a quantitative suspension test. J Hosp Infect 48:214221.
172. Walsh SE,, Maillard JY,, Russell AD. 1999. Ortho-phthalaldehyde: a possible alternative to glutaraldehyde for high level disinfection. J Appl Microbiol 86:10391046.
173. Rossmoore HW,, Sondossi M. 1988. Applications and mode of action of formaldehyde condensate biocides. Adv Appl Microbiol 33:223277.
174. Akbar-Khanzadeh F,, Vaquerano MU,, Akbar-Khanzadeh M,, Bisesi MS. 1994. Formaldehyde exposure, acute pulmonary response, and exposure control options in a gross anatomy laboratory. Am J Ind Med 26:6175.
175. Rutala WA,, Weber DJ. 1997. Uses of inorganic hypochlorite (bleach) in health-care facilities. Clin Microbiol Rev 10:597610.
176. Karol MH. 1995. Toxicologic principles do not support the banning of chlorine. A Society of Toxicology position paper. Fundam Appl Toxicol 24:12.
177. Williams ND,, Russell AD. 1991. The effects of some halogen-containing compounds on Bacillus subtilis endospores. J Appl Bacteriol 70:427436.
178. Kaatz GW,, Gitlin SD,, Schaberg DR,, Wilson KH,, Kauffman CA,, Seo SM,, Fekety R. 1988. Acquisition of Clostridium difficile from the hospital environment. Am J Epidemiol 127:12891293.
179. Centers for Disease Control and Prevention. 2001. Protracted outbreaks of cryptosporidiosis associated with swimming pool use—Ohio and Nebraska, 2000. MMWR Morb Mortal Wkly Rep 50:406410.
180. Helms CM,, Massanari RM,, Wenzel RP,, Pfaller MA,, Moyer NP,, Hall N. 1988. Legionnaires’ disease associated with a hospital water system. A five-year progress report on continuous hyperchlorination. JAMA 259:24232427.
181. Centers for Disease Control and Prevention. 1989. Guidelines for prevention of transmission of human immunodeficiency virus and hepatitis B virus to health-care and public-safety workers. MMWR Morb Mortal Wkly Rep 38(Suppl 6):137.
182. Chitnis V,, Chitnis S,, Patil S,, Chitnis D. 2004. Practical limitations of disinfection of body fluid spills with 10,000 ppm sodium hypochlorite (NaOCl). Am J Infect Control 32:306308.
183. Flynn N,, Jain S,, Keddie EM,, Carlson JR,, Jennings MB,, Haverkos HW,, Nassar N,, Anderson R,, Cohen S,, Goldberg D. 1994. In vitro activity of readily available household materials against HIV-1: is bleach enough? J Acquir Immune Defic Syndr 7:747753.
184. Weber DJ,, Barbee SL,, Sobsey MD,, Rutala WA. 1999. The effect of blood on the antiviral activity of sodium hypochlorite, a phenolic, and a quaternary ammonium compound. Infect Control Hosp Epidemiol 20:821827.
185. Centers for Disease Control and Prevention. 1996. Community-level prevention of human immunodeficiency virus infection among high-risk populations: the AIDS community demonstration projects. MMWR Recommend Rep 45(RR-6):131.
186. Hamilton E,, Seal DV,, Hay J. 1996. Comparison of chlorine and chlorine dioxide disinfection for control of Legionella in a hospital potable water supply. J Hosp Infect 32:156160.
187. Kool JL,, Carpenter JC,, Fields BS. 1999. Effect of monochloramine disinfection of municipal drinking water on risk of nosocomial Legionnaires’ disease. Lancet 353:272277.
188. Lever AM,, Sutton SVW. 1996. Antimicrobial effects of hydrogen peroxide as an antiseptic and disinfectant, p 159176. In Ascenzi JP (ed), Handbook of Disinfectants and Antiseptics. Marcel Dekker, Inc, New York, NY.
189. Mathers WD,, Sutphin JE,, Folberg R,, Meier PA,, Wenzel RP,, Elgin RG. 1996. Outbreak of keratitis presumed to be caused by Acanthamoeba. Am J Ophthalmol 121:129142.
190. Wardle MD,, Renninger GM. 1975. Bactericidal effect of hydrogen peroxide on spacecraft isolates. Appl Microbiol 30:710711.
191. Leaper S. 1984. Influence of temperature on the synergistic sporicidal effect of peracetic acid plus hydrogen peroxide in Bacillus subtilis SA22 (NCA 72–52). Food Microbiol 1:199203.
192. Sagripanti JL,, Bonifacino A. 1996. Comparative sporicidal effect of liquid chemical germicides on three medical devices contaminated with spores of Bacillus subtilis. Am J Infect Control 24:364371.
193. Alasri A,, Valverde M,, Roques C,, Michel G,, Cabassud C,, Aptel P. 1993. Sporocidal properties of peracetic acid and hydrogen peroxide, alone and in combination, in comparison with chlorine and formaldehyde for ultrafiltration membrane disinfection. Can J Microbiol 39:5260.
194. Mentel R,, Schmidt J. 1973. Investigations on rhinovirus inactivation by hydrogen peroxide. Acta Virol 17:351354.
195. Ryan CK,, Potter GD. 1995. Disinfectant colitis. Rinse as well as you wash. J Clin Gastroenterol 21:69.
196. Hughes R,, Kilvington S. 2001. Comparison of hydrogen peroxide contact lens disinfection systems and solutions against Acanthamoeba polyphaga. Antimicrob Agents Chemother 45:20382043.
197. Levenson JE. 1989. Corneal damage from improperly cleaned tonometer tips. Arch Ophthalmol 107:1117.
198. Alasri A,, Roques C,, Michel G,, Cabassud C,, Aptel P. 1992. Bactericidal properties of peracetic acid and hydrogen peroxide, alone and in combination, and chlorine and formaldehyde against bacterial water strains. Can J Microbiol 38:635642.
199. Sagripanti JL,, Eklund CA,, Trost PA,, Jinneman KC,, Abeyta CJ,, Kaysner CA,, Hill WE. 1997. Comparative sensitivity of 13 species of pathogenic bacteria to seven chemical germicides. Am J Infect Control 25:335339.
200. Held PJ,, Wolfe RA,, Gaylin DS,, Port FK,, Levin NW,, Turenne MN. 1994. Analysis of the association of dialyzer reuse practices and patient outcomes. Am J Kidney Dis 23:692708.
201. Feldman HI,, Kinosian M,, Bilker WB,, Simmons C,, Holmes JH,, Pauly MV,, Escarce JJ. 1996. Effect of dialyzer reuse on survival of patients treated with hemodialysis. JAMA 276:1724.
202. O’Connor DO,, Rubino JR,. 1991. Phenolic compounds, p 204224. In Block SS (ed), Disinfection, Sterilization and Preservation. Lea & Febiger, Philadelphia, PA.
203. Rutala WA,, Cole EC. 1987. Ineffectiveness of hospital disinfectants against bacteria: a collaborative study. Infect Control 8:501506.
204. Terleckyj B,, Axler DA. 1987. Quantitative neutralization assay of fungicidal activity of disinfectants. Antimicrob Agents Chemother 31:794798.
205. Narang HK,, Codd AA. 1983. Action of commonly used disinfectants against enteroviruses. J Hosp Infect 4:209212.
206. Druce JD,, Jardine D,, Locarnini SA,, Birch CJ. 1995. Susceptibility of HIV to inactivation by disinfectants and ultraviolet light. J Hosp Infect 30:167180.
207. Sattar SA,, Jacobsen H,, Rahman H,, Cusack TM,, Rubino JR. 1994. Interruption of rotavirus spread through chemical disinfection. Infect Control Hosp Epidemiol 15:751756.
208. Merianos JJ,. 1991. Quaternary ammonium antimicrobial compounds, p 225255. In Block SS (ed), Disinfection, Sterilization and Preservation. Lea & Febiger, Philadelphia, PA.
209. Rutala WA,, Cole EC,, Wannamaker NS,, Weber DJ. 1991. Inactivation of Mycobacterium tuberculosis and Mycobacterium bovis by 14 hospital disinfectants. Am J Med 91:267S271S.
210. Frank MJ,, Schaffner W. 1976. Contaminated aqueous benzalkonium chloride. An unnecessary hospital infection hazard. JAMA 236:24182419.
211. Nakashima AK,, Highsmith AK,, Martone WJ. 1987. Survival of Serratia marcescens in benzalkonium chloride and in multiple-dose medication vials: relationship to epidemic septic arthritis. J Clin Microbiol 25:10191021.
212. Tiwari TS,, Ray B,, Jost KCJr,, Rathod MK,, Zhang Y,, Brown-Elliott BA,, Hendricks K,, Wallace RJJr. 2003. Forty years of disinfectant failure: outbreak of postinjection Mycobacterium abscessus infection caused by contamination of benzalkonium chloride. Clin Infect Dis 36:954962.
213. Casalegno JS,, Le Bail Carval K,, Eibach D,, Valdeyron ML,, Lamblin G,, Jacquemoud H,, Mellier G,, Lina B,, Gaucherand P,, Mathevet P,, Mekki Y. 2012. High risk HPV contamination of endocavity vaginal ultrasound probes: an underestimated route of nosocomial infection? PLoS One 7:e48137.
214. Disch K. 1994. Glucoprotamine—a new antimicrobial substance. Zentralbl Hyg Umweltmed 195:357365.
215. Meyer B,, Kluin C. 1999. Efficacy of Glucoprotamin containing disinfectants against different species of atypical mycobacteria. J Hosp Infect 42:151154.
216. Widmer AF. 2003. Antimicrobial activity of glucoprotamin: a clinical study of a new disinfectant for instruments. Infect Control Hosp Epidemiol 24:762764.
217. Coates D. 1996. Sporicidal activity of sodium dichloroisocyanurate, peroxygen and glutaraldehyde disinfectants against Bacillus subtilis. J Hosp Infect 32:283294.
218. Broadley SJ,, Furr JR,, Jenkins PA,, Russell AD. 1993. Antimycobacterial activity of ‘Virkon’. J Hosp Infect 23:189197.
219. Middleton AM,, Chadwick MV,, Sanderson JL,, Gaya H. 2000. Comparison of a solution of super-oxidized water (Sterilox) with glutaraldehyde for the disinfection of bronchoscopes, contaminated. J Hosp Infect 45:278282.
220. Shetty N,, Srinivasan S,, Holton J,, Ridgway GL. 1999. Evaluation of microbicidal activity of a new disinfectant: Sterilox 2500 against Clostridium difficile spores, Helicobacter pylori, vancomycin resistant Enterococcus species, Candida albicans and several Mycobacterium species. J Hosp Infect 41:101105.
221. Sagripanti JL. 1992. Metal-based formulations with high microbicidal activity. Appl Environ Microbiol 58:31573162.
222. Stout JE,, Lin YS,, Goetz AM,, Muder RR. 1998. Controlling Legionella in hospital water systems: experience with the superheat-and-flush method and copper-silver ionization. Infect Control Hosp Epidemiol 19:911914.
223. Brady MJ,, Lisay CM,, Yurkovetskiy AV,, Sawan SP. 2003. Persistent silver disinfectant for the environmental control of pathogenic bacteria. Am J Infect Control 31:208214.
224. Rutala WA,, Weber DJ. 2001. New disinfection and sterilization methods. Emerg Infect Dis 7:348353.
225. Archibald LK,, Corl A,, Shah B,, Schulte M,, Arduino MJ,, Aguero S,, Fisher DJ,, Stechenberg BW,, Banerjee SN,, Jarvis WR. 1997. Serratia marcescens outbreak associated with extrinsic contamination of 1% chlorxylenol soap. Infect Control Hosp Epidemiol 18:704709.
226. Bosi C,, Davin-Regli A,, Charrel R,, Rocca B,, Monnet D,, Bollet C. 1996. Serratia marcescens nosocomial outbreak due to contamination of hexetidine solution. J Hosp Infect 33:217224.
227. Vigeant P,, Loo VG,, Bertrand C,, Dixon C,, Hollis R,, Pfaller MA,, McLean AP,, Briedis DJ,, Perl TM,, Robson HG. 1998. An outbreak of Serratia marcescens infections related to contaminated chlorhexidine. Infect Control Hosp Epidemiol 19:791794.
228. Tschudin-Sutter S,, Frei R,, Kampf G,, Tamm M,, Pflimlin E,, Battegay M,, Widmer AF. 2011. Emergence of glutaraldehyde-resistant Pseudomonas aeruginosa. Infect Control Hosp Epidemiol 32:11731178.
229. Perencevich EN,, Wong MT,, Harris AD. 2001. National and regional assessment of the antibacterial soap market: a step toward determining the impact of prevalent antibacterial soaps. Am J Infect Control 29:281283.
230. Fraise AP,, Lambert PA,, Maillard JY. 2004. Russell, Hugo and Ayliffe’s Principles and Practice of Disinfections, Preservation and Sterilization. Blackwell Publishing, Malden, MA.
231. Maillard JY. 2002. Bacterial target sites for biocide action. J Appl Microbiol 92(Suppl):16S27S.
232. Sheldon ATJr. 2005. Antiseptic “resistance”: real or perceived threat? Clin Infect Dis 40:16501656.
233. Weber DJ,, Sickbert-Bennett E,, Gergen MF,, Rutala WA. 2003. Efficacy of selected hand hygiene agents used to remove Bacillus atrophaeus (a surrogate of Bacillus anthracis) from contaminated hands. JAMA 289:12741277.
234. Rutala WA,, Weber DJ. 2004. Disinfection and sterilization in health care facilities: what clinicians need to know. Clin Infect Dis 39:702709.
235. Lai MY,, Cheng PK,, Lim WW. 2005. Survival of severe acute respiratory syndrome coronavirus. Clin Infect Dis 41:e67e71.
236. Wullt M,, Odenholt I,, Walder M. 2003. Activity of three disinfectants and acidified nitrite against Clostridium difficile spores. Infect Control Hosp Epidemiol 24:765768.
237. Orenstein R,, Aronhalt KC,, McManus JEJr,, Fedraw LA. 2011. A targeted strategy to wipe out Clostridium difficile. Infect Control Hosp Epidemiol 32:11371139.
238. Fenner L,, Widmer AF,, Stranden A,, Conzelmann M,, Goorhuis A,, Harmanus C,, Kuijper EJ,, Frei R. 2008. First cluster of clindamycin-resistant Clostridium difficile PCR ribotype 027 in Switzerland. Clin Microbiol Infect 14:514515.
239. McDonald LC,, Killgore GE,, Thompson A,, Owens RCJr,, Kazakova SV,, Sambol SP,, Johnson S,, Gerding DN. 2005. An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med 353:24332441.
240. Wilcox MH,, Fawley WN. 2000. Hospital disinfectants and spore formation by Clostridium difficile. Lancet 356:1324.
241. Hall CB,, Douglas RGJr. 1981. Modes of transmission of respiratory syncytial virus. J Pediatr 99:100103.
242. Gamage B,, Moore D,, Copes R,, Yassi A,, Bryce E. 2005. Protecting HCWs from SARS and other respiratory pathogens: a review of the infection control literature. Am J Infect Control 33:114121.
243. Wysowski DK,, Flynt JWJ,, Goldfield M,, Altman R,, Davis AT. 1978. Epidemic neonatal hyperbilirubinemia and use of a phenolic disinfectant detergent. Pediatrics 61:165170.
244. de Lassence A,, Hidri N,, Timsit JF,, Joly-Guillou ML,, Thiery G,, Boyer A,, Lable P,, Blivet A,, Kalinowski H,, Martin Y,, Lajonchere JP,, Dreyfuss D. 2006. Control and outcome of a large outbreak of colonization and infection with glycopeptide-intermediate Staphylococcus aureus in an intensive care unit. Clin Infect Dis 42:170178.
245. Clay S,, Maherchandani S,, Malik YS,, Goyal SM. 2006. Survival on uncommon fomites of feline calicivirus, a surrogate of noroviruses. Am J Infect Control 34:4143.
246. Dancer SJ. 2008. Importance of the environment in methicillin-resistant Staphylococcus aureus acquisition: the case for hospital cleaning. Lancet Infect Dis 8:101113.
247. Khanna N,, Goldenberger D,, Graber P,, Battegay M,, Widmer AF. 2003. Gastroenteritis outbreak with norovirus in a Swiss university hospital with a newly identified virus strain. J Hosp Infect 55:131136.
248. Boyce JM,, Havill NL,, Otter JA,, McDonald LC,, Adams NM,, Cooper T,, Thompson A,, Wiggs L,, Killgore G,, Tauman A,, Noble-Wang J. 2008. Impact of hydrogen peroxide vapor room decontamination on Clostridium difficile environmental contamination and transmission in a healthcare setting. Infect Control Hosp Epidemiol 29:723729.
249. Passaretti CL,, Otter JA,, Reich NG,, Myers J,, Shepard J,, Ross T,, Carroll KC,, Lipsett P,, Perl TM. 2013. An evaluation of environmental decontamination with hydrogen peroxide vapor for reducing the risk of patient acquisition of multidrug-resistant organisms. Clin Infect Dis 56:2735.
250. Jeanes A,, Rao G,, Osman M,, Merrick P. 2005. Eradication of persistent environmental MRSA. J Hosp Infect 61:8586
251. Dryden M,, Parnaby R,, Dailly S,, Lewis T,, Davis-Blues K,, Otter JA,, Kearns AM. 2008. Hydrogen peroxide vapour decontamination in the control of a polyclonal methicillin-resistant Staphylococcus aureus outbreak on a surgical ward. J Hosp Infect 68:190192.
252. Otter JA,, Yezli S,, Schouten MA,, van Zanten AR,, Houmes-Zielman G,, Nohlmans-Paulssen MK. 2010 Hydrogen peroxide vapor decontamination of an intensive care unit to remove environmental reservoirs of multidrug-resistant Gram-negative rods during an outbreak. Am J Infect Control 38:754756
253. Otter JA,, Yezli S,, Perl MZ,, Barbut F,, French GL. 2013. The role of ‘no-touch’ automated room disinfection systems in infection prevention and control. J Hosp Infect 83:113.
254. Belay ED,, Schonberger LB. 2005. The public health impact of prion diseases. Annu Rev Public Health 26:191212.
255. Collins SJ,, Lawson VA,, Masters CL. 2004. Transmissible spongiform encephalopathies. Lancet 363:5161.
256. Weissmann C. 2005. Birth of a prion: spontaneous generation revisited. Cell 122:165168.
257. Spaulding EH,. 1968. Chemical disinfection of medical and surgical materials, p 517531. In Block S (ed), Disinfection, Sterilization and Preservation. Lea & Febiger, Philadelphia, PA.
258. Prusiner SB. 1982. Novel proteinaceous infectious particles cause scrapie. Science 216:136144.
259. Cetinkaya Y,, Falk P,, Mayhall CG. 2000. Vancomycin-resistant enterococci. Clin Microbiol Rev 13:686707.
260. Martin MA,, Reichelderfer M, , et al. 1994. APIC guidelines for infection prevention and control in flexible endoscopy. Am J Infect Control 22:1938.
261. Corne P,, Godreuil S,, Jean-Pierre H,, Jonquet O,, Campos J,, Jumas-Bilak E,, Parer S,, Marchandin H. 2005. Unusual implication of biopsy forceps in outbreaks of Pseudomonas aeruginosa infections and pseudo-infections related to bronchoscopy. J Hosp Infect 61:2026.
262. Deva AK,, Vickery K,, Zou J,, West RH,, Harris JP,, Cossart YE. 1996. Establishment of an in-use testing method for evaluating disinfection of surgical instruments using the duck hepatitis B model. J Hosp Infect 33:119130.
263. Wu MS,, Wang JT,, Yang JC,, Wang HH,, Sheu JC,, Chen DS,, Wang TH. 1996. Effective reduction of Helicobacter pylori infection after upper gastrointestinal endoscopy by mechanical washing of the endoscope. Hepatogastroenterology 43:16601664.
264. Kaczmarek RG,, Moore RMJ,, McCrohan J,, Goldmann DA,, Reynolds C,, Caquelin C,, Israel E. 1992. Multi-state investigation of the actual disinfection/sterilization of endoscopes in health care facilities. Am J Med 92:257261.
265. Favero MS. 1991. Strategies for disinfection and sterilization of endoscopes: the gap between basic principles and actual practice. Infect Control Hosp Epidemiol 12:279281.
266. Gorse GJ,, Messner RL. 1991. Infection control practices in gastrointestinal endoscopy in the United States: a national survey. Infect Control Hosp Epidemiol 12:289296.
267. Cheung RJ,, Ortiz D,, DiMarino AJJr. 1999. GI endoscopic reprocessing practices in the United States. Gastrointest Endosc 50:362368.
268. Robertson LJ,, Campbell AT,, Smith HV. 1992. Survival of Cryptosporidium parvum oocysts under various environmental pressures. Appl Environ Microbiol 58:34943500.
269. Akamatsu T,, Tabata K,, Hironaga M,, Uyeda M. 1997. Evaluation of the efficacy of a 3.2% glutaraldehyde product for disinfection of fibreoptic endoscopes with an automatic machine. J Hosp Infect 35:4757.
270. Fraser VJ,, Zuckerman G,, Clouse RE,, O’Rourke S,, Jones M,, Klasner J,, Murray P. 1993. A prospective randomized trial comparing manual and automated endoscope disinfection methods. Infect Control Hosp Epidemiol 14:383389.
271. Centers for Disease Control and Prevention. 1999. Bronchoscopy-related infections and pseudoinfections—New York, 1996 and 1998. MMWR Morb Mortal Wkly Rep 48:557560.
272. Bradley CR,, Babb JR,, Ayliffe GA. 1995. Evaluation of the Steris System 1 peracetic acid endoscope processor. J Hosp Infect 29:143151.
273. Axon A,, Jung M,, Kruse A,, Ponchon T,, Rey JF,, Beilenhoff U,, Duforest-Rey D,, Neumann C,, Pietsch M,, Roth K,, Papoz A,, Wilson D,, Kircher-Felgenstreff I,, Stief M,, Blum R,, Spencer KB,, Mills J,, Mart EP,, Slowey B,, Biering H,, Lorenz U, , et al. 2000. The European Society of Gastrointestinal Endoscopy (ESGE): check list for the purchase of washer-disinfectors for flexible endoscopes. Endoscopy 32:914919.
274. Beilenhoff U,, Neumann CS,, Rey JF,, Biering H,, Blum R,, Cimbro M,, Kampf B,, Rogers M,, Schmidt V. 2008. ESGE-ESGENA guideline: cleaning and disinfection in gastrointestinal endoscopy. Endoscopy 40:939957.
275. Farina A,, Fievet MH,, Plassart F,, Menet MC,, Thuillier A. 1999. Residual glutaraldehyde levels in fiberoptic endoscopes: measurement and implications for patient toxicity. J Hosp Infect 43:293297.
276. Gurevich I,, Dubin R,, Cunha BA. 1996. Dental instrument and device sterilization and disinfection practices. J Hosp Infect 32:295304.
277. Bagg J,, Sweeney CP,, Roy KM,, Sharp T,, Smith A. 2001. Cross infection control measures and the treatment of patients at risk of Creutzfeldt Jakob disease in UK general dental practice. Br Dent J 191:8790.
278. Healy CM,, Kearns HP,, Coulter WA,, Stevenson M,, Burke FJ. 2004. Autoclave use in dental practice in the Republic of Ireland. Int Dent J 54:182186.
279. Monarca S,, Grottolo M,, Renzi D,, Paganelli C,, Sapelli P,, Zerbini I,, Nardi G. 2000. Evaluation of environmental bacterial contamination and procedures to control cross infection in a sample of Italian dental surgeries. Occup Environ Med 57:721726.
280. Piazza M,, Borgia G,, Picciotto L,, Nappa S,, Cicciarello S,, Orlando R. 1995. Detection of hepatitis C virus-RNA by polymerase chain reaction in dental surgeries. J Med Virol 45:4042.
281. ADA Council on Scientific Affairs and ADA Council on Dental Practice. 1996. Infection control recommendations for the dental office and the dental laboratory. J Am Dent Assoc 127:672680.
282. Centers for Disease Control and Prevention. 1993. Recommended infection-control practices for dentistry. MMWR Morb Mortal Wkly Rep 42:112.
283. Rutala WA. 1996. Disinfection and sterilization of patient-care items. Infect Control Hosp Epidemiol 17:377384.
284. Scherrer M,, Kümmerer K. 1997. Manual and automated processing of medical instruments. Environmental and economic aspects. Central Service 5:183194.
285. Gurevich I,, Tafuro P,, Ristuccia P,, Herrmann J,, Young AR,, Cunha BA. 1983. Disinfection of respirator tubing: a comparison of chemical versus hot water machine-assisted processing. J Hosp Infect 4:199208.
286. Bradley CR,, Fraise AP. 1996. Heat and chemical resistance of enterococci. J Hosp Infect 34:191196.
287. U.S. Food and Drug Administation. 2002. Medical devices: classification for medical washer and medical washer disinfector. Fed Regist 67:6911969121.
288. Borchardt MA,, Bertz PD,, Spencer SK,, Battigelli DA. 2003. Incidence of enteric viruses in groundwater from household wells in Wisconsin. Appl Environ Microbiol 69:11721180.
289. Zuhlsdorf B,, Kampf G,, Floss H,, Martiny H. 2005. Suitability of the German test method for cleaning efficacy in washer-disinfectors for flexible endoscopes according to prEN ISO 15883. J Hosp Infect 61:4652.
290. Zuhlsdorf B,, Martiny H. 2005. Intralaboratory reproducibility of the German test method of prEN ISO 15883–1 for determination of the cleaning efficacy of washer-disinfectors for flexible endoscopes. J Hosp Infect 59:286291.
291. Joslyn LJ,. 1991. Sterilization by heat, p 495526. In Block SS (ed), Disinfection, Sterilization and Preservation. Lea & Febiger, Philadelphia, PA.
292. Graham GS,. 1997. Decontamination: scientific principles, p 19. In Reichert M,, Young JH (ed), Sterilization Technology. Aspen Publishers, Gaithersburg, MD.
293. Rutala WA,, Gergen MF,, Weber DJ. 1993. Evaluation of a rapid readout biological indicator for flash sterilization with three biological indicators and three chemical indicators. Infect Control Hosp Epidemiol 14:390394.
294. Rutala WA,, Jones SM,, Weber DJ. 1996. Comparison of a rapid readout biological indicator for steam sterilization with four conventional biological indicators and five chemical indicators. Infect Control Hosp Epidemiol 17:423428.
295. Bowie JH,, Kennedy MH,, Robertson I. 1975. Improved Bowie and Dick test. Lancet i:1135.
296. Vesley D,, Nellis MA,, Allwood PB. 1995. Evaluation of a rapid readout biological indicator for 121 degrees C gravity and 132 degrees C vacuum-assisted steam sterilization cycles. Infect Control Hosp Epidemiol 16:281286.
297. Bryce EA,, Roberts FJ,, Clements B,, MacLean S. 1997. When the biological indicator is positive: investigating autoclave failures. Infect Control Hosp Epidemiol 18:654656.
298. van Doornmalen JP,, Dankert J. 2005. A validation survey of 197 hospital steam sterilizers in The Netherlands in 2001 and 2002. J Hosp Infect 59:126130.
299. Widmer AF,, Houston A,, Bollinger E,, Wenzel RP. 1992. A new standard for sterility testing for autoclaved surgical trays. J Hosp Infect 21:253260.
300. Crow S. 1993. Steam sterilizers: an evolution in design. Infect Control Hosp Epidemiol 14:488490.
301. Maki DG,, Hassemer CA. 1987. Flash sterilization: carefully measured haste. Infect Control 8:307310.
302. Rutala WA,, Weber DJ,, Chappell KJ. 1999. Patient injury from flash-sterilized instruments. Infect Control Hosp Epidemiol 20:458.
303. Favero MS,, Manian FA. 1993. Is eliminating flash sterilization practical? Infect Control Hosp Epidemiol 14:479480.
304. Rutala WA,, Gergen MF,, Weber DJ. 1999. Sporicidal activity of a new low-temperature sterilization technology: the Sterrad 50 sterilizer. Infect Control Hosp Epidemiol 20:514516.
305. Daschner F. 1994. Steris System 1 in Germany. Infect Control Hosp Epidemiol 15:294, 296.
306. Holton J,, Shetty N. 1997. In-use stability of Nu-Cidex. J Hosp Infect 35:245248.
307. Hussaini SN,, Ruby KR. 1976. Sporicidal activity of peracetic acid against B. anthracis spores. Vet Rec 98:257259.
308. Wallace J,, Agee PM,, Demicco DM. 1995. Liquid chemical sterilization using peracetic acid. An alternative approach to endoscope processing. ASAIO J 41:151154.
309. Mannion PT. 1995. The use of peracetic acid for the reprocessing of flexible endoscopes and rigid cystoscopes and laparoscopes. J Hosp Infect 29:313315.
310. Kralovic RC. 1993. Use of biological indicators designed for steam or ethylene oxide to monitor a liquid chemical sterilization process. Infect Control Hosp Epidemiol 14:313319.
311. Gurevich I,, Qadri SM,, Cunha BA. 1993. False-positive results of spore tests from improper clip use with the STERIS chemical sterilant system. Am J Infect Control 21:4243.
312. Fuselier HAJ,, Mason C. 1997. Liquid sterilization versus high level disinfection in the urologic office. Urology 50:337340.
313. Bruce ME,, Will RG,, Ironside JW,, McConnell I,, Drummond D,, Suttie A,, McCardle L,, Chree A,, Hope J,, Birkett C,, Cousens S,, Fraser H,, Bostock CJ. 1997. Transmissions to mice indicate that ‘new variant’ CJD is caused by the BSE agent. Nature 389:498501.
314. Kawashima T,, Furukawa H,, Doh-ura K,, Iwaki T. 1997. Diagnosis of new variant Creutzfeldt-Jakob disease by tonsil biopsy. Lancet 350:6869.
315. Prusiner SB. 1997. Prion diseases and the BSE crisis. Science 278:245251.
316. Glatzel M,, Stoeck K,, Seeger H,, Luhrs T,, Aguzzi A. 2005. Human prion diseases: molecular and clinical aspects. Arch Neurol 62:545552.
317. Hill AF,, Desbruslais M,, Joiner S,, Sidle KC,, Gowland I,, Collinge J,, Doey LJ,, Lantos P. 1997. The same prion strain causes vCJD and BSE. Nature 389:448450.
318. Aguzzi A,, Weissmann C. 1998. Spongiform encephalopathies. The prion’s perplexing persistence. Nature 392:763764.
319. Blattler T,, Brandner S,, Raeber AJ,, Klein MA,, Voigtlander T,, Weissmann C,, Aguzzi A. 1997. PrP-expressing tissue required for transfer of scrapie infectivity from spleen to brain. Nature 389:6973.
320. Sailer A,, Bueler H,, Fischer M,, Aguzzi A,, Weissmann C. 1994. No propagation of prions in mice devoid of PrP. Cell 77:967968.
321. Chazot G,, Broussolle E,, Lapras C,, Blattler T,, Aguzzi A,, Kopp N. 1996. New variant of Creutzfeldt-Jakob disease in a 26-year-old French man. Lancet 347:1181.
322. Valleron AJ,, Boelle PY,, Will R,, Cesbron JY. 2001. Estimation of epidemic size and incubation time based on age characteristics of vCJD in the United Kingdom. Science 294:17261728.
323. Gill ON,, Spencer Y. 2013. Prevalent abnormal prion protein in human appendixes after bovine spongiform encephalopathy epizootic: large scale survey. BMJ 347:f5675.
324. Herzog C,, Sales N,, Etchegaray N,, Charbonnier A,, Freire S,, Dormont D,, Deslys JP,, Lasmezas CI. 2004. Tissue distribution of bovine spongiform encephalopathy agent in primates after intravenous or oral infection. Lancet 363:422428.
325. Klein MA,, Frigg R,, Flechsig E,, Raeber AJ,, Kalinke U,, Bluethman H,, Bootz F,, Suter J,, Zinkernagel RM,, Aguzzi A. 1997. A crucial role for B cells in neuroinvasive scrapie. Nature 390:687.
326. Heikenwalder M,, Zeller N,, Seeger H,, Prinz M,, Klohn PC,, Schwarz P,, Ruddle NH,, Weissmann C,, Aguzzi A. 2005. Chronic lymphocytic inflammation specifies the organ tropism of prions. Science 307:11071110.
327. Aguzzi A,, Glatzel M. 2004. vCJD tissue distribution and transmission by transfusion—a worst-case scenario coming true? Lancet 363:411412.
328. Kampf G,, Bloss R,, Martiny H. 2004. Surface fixation of dried blood by glutaraldehyde and peracetic acid. J Hosp Infect 57:139143.
329. Taylor DM. 1999. Inactivation of prions by physical and chemical means. J Hosp Infect 43(Suppl):S69S76.
330. Dormont D. 1996. How to limit the spread of Creutzfeldt-Jakob disease. Infect Control Hosp Epidemiol 17:521528.
331. Taylor DM,, Woodgate SL,, Fleetwood AJ,, Cawthorne RJ. 1997. Effect of rendering procedures on the scrapie agent. Vet Rec 141:643649.
332. Charatan F. 2001. United States takes precautions against BSE. West J Med 174:235.
333. World Health Organization. 1983. Laboratory Safety Manual. World Health Organization, Geneva, Switzerland.
334. Larson E. 1988. Guideline for use of topical antimicrobial agents. Am J Infect Control 16:253266.
335. DiazGranados CA,, Jones MY,, Kongphet-Tran T,, White N,, Shapiro M,, Wang YF,, Ray SM,, Blumberg HM. 2009. Outbreak of Pseudomonas aeruginosa infection associated with contamination of a flexible bronchoscope. Infect Control Hosp Epidemiol 30:550555.
336. Shimono N,, Takuma T,, Tsuchimochi N,, Shiose A,, Murata M,, Kanamoto Y,, Uchida Y,, Morita S,, Matsumoto H,, Hayashi J. 2008. An outbreak of Pseudomonas aeruginosa infections following thoracic surgeries occurring via the contamination of bronchoscopes and an automatic endoscope reprocessor. J Infect Chemother 14:418423.
337. Bou R,, Aguilar A,, Perpinan J,, Ramos P,, Peris M,, Lorente L,, Zuniga A. 2006. Nosocomial outbreak of Pseudomonas aeruginosa infections related to a flexible bronchoscope. J Hosp Infect 64:129135.
338. Cetre JC,, Nicolle MC,, Salord H,, Perol M,, Tigaud S,, David G,, Bourjault M,, Vanhems P. 2005. Outbreaks of contaminated broncho-alveolar lavage related to intrinsically defective bronchoscopes. J Hosp Infect 61:3945.
339. Fraser TG,, Reiner S,, Malczynski M,, Yarnold PR,, Warren J,, Noskin GA. 2004. Multidrug-resistant Pseudomonas aeruginosa cholangitis after endoscopic retrograde cholangiopancreatography: failure of routine endoscope cultures to prevent an outbreak. Infect Control Hosp Epidemiol 25:856859.
340. Sorin M,, Segal-Maurer S,, Mariano N,, Urban C,, Combest A,, Rahal JJ. 2001. Nosocomial transmission of imipenem-resistant Pseudomonas aeruginosa following bronchoscopy associated with improper connection to the Steris System 1 processor. Infect Control Hosp Epidemiol 22:409413.
341. Rutala WA,, Weber DJ. 1999. Disinfection of endoscopes: review of new chemical sterilants used for high-level disinfection. Infect Control Hosp Epidemiol 20:6976.
342. Bronowicki JP,, Venard V,, Botte C,, Monhoven N,, Gastin I,, Chone L,, Hudziak H,, Rhin B,, Delanoe C,, LeFaou A,, Bigard MA,, Gaucher P. 1997. Patient-to-patient transmission of hepatitis C virus during colonoscopy. N Engl J Med 337:237240.
343. Michele TM,, Cronin WA,, Graham NM,, Dwyer DM,, Pope DS,, Harrington S,, Chaisson RE,, Bishai WR. 1997. Transmission of Mycobacterium tuberculosis by a fi